Mastering Patient Compliance: Strategies for Glaucoma Drop Adherence

Non-compliance with topical glaucoma therapy is the leading cause of progressive visual loss. Learn proven strategies, from simple alarms to fixed-combination drops, to keep patients on track.

In the management of glaucoma, the most elegantly calculated target IOP is clinically useless if the prescribed medication never makes it into the eye. Studies consistently show that up to 50% of glaucoma patients become non-compliant within the first six months of therapy.

The Barriers to Compliance

Patients face multiple hurdles: complex multi-drop regimens, ocular surface toxicity (often driven by BAK preservatives), forgetfulness, and the fundamental challenge of treating an asymptomatic disease. Why take drops that burn your eyes when you feel perfectly fine?

Actionable Clinical Strategies

• Simplification: Aggressively migrate patients to fixed-combination therapies whenever possible to reduce the physical number of drops required daily.
• Preservative-Free Options: Address ocular surface disease pre-emptively. A comfortable eye is much more likely to receive its nightly medication.
• Visual Feedback: Use tools like the Glaucoma One dashboard to physically show patients their VFI trajectory. Seeing a chart that visually links their drop compliance to their long-term vision retention is far more powerful than a simple verbal warning.
• Surgical Alternatives: When all else fails, consider shifting the compliance burden entirely via SLT or MIGS procedures.